Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials

SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, has announced that its collaborative work with HanX Biopharmaceutical Co., Ltd. (“HanX”), employing a unique and broad portfolio of preclinical modeling in support of HanX’s successful FDA Investigational New Drug (IND) application, has been published in Scientific Reports, a journal within the Nature portfolio. The study demonstrated that HX009, an investigational “first-i
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks